Previous 10 | Next 10 |
Glaukos Corporation (GKOS) has lost ~13.0% in the pre-market after Wells Fargo Securities downgraded the stock to underweight from equal-weight, citing the headwinds to the top-line from the proposed reimbursement cuts to the company’s iStent device.In the proposed rules issu...
Artystarty/iStock via Getty Images Thanks to the prospects of earning a spot in the S&P 500 Index, Moderna (MRNA) jumped ~23.0% this week to breeze past $100B market capitalization. The frontrunner in COVID-19 vaccine development has taken less than three yea...
Teleflex Incorporated (TFX) and Itamar Medical (ITMR) fell sharply on Thursday after the newly released reimbursement, rates published by the Centers for Medicare and Medicaid Services ((CMS)), indicated sharp cuts to reimbursement rates for company’s products.Today, Teleflex has recov...
Conference Call and Webcast Scheduled for 1:30 p.m. PDT Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release second qua...
naphtalina/iStock via Getty Images Federal Reserve Chairman Jerome Powell may have dominated headlines throughout Wednesday's session. But Wall Street still saw a few standout performances that had little to do with monetary policy or inflation. CorePoint Lodging (CPLG), for example, posted o...
Shares of Glaukos (NYSE: GKOS) were tanking on Wednesday, with the stock down 20.5% as of 10:38 a.m. EDT. The decline came after the Centers for Medicare and Medicaid Services (CMS) released its proposed physician fee schedule for fiscal year 2022. The proposed fee schedule wasn...
Gainers: AcelRx Pharmaceuticals ACRX +19%, GBS (GBS) +13%, Navidea Biopharmaceuticals (NAVB) +7%, Cellect Biotechnology (APOP) +6%, Adagene (ADAG) +2%.Losers: Allied Healthcare Products (AHPI) -34%, Allena Pharmaceuticals (ALNA) -31%, SCWorx (WORX)...
The shares of Glaukos (GKOS) and Inspire Medical Systems (INSP) have lost ~21.5% and ~6.4% in the pre-market in apparent reaction to newly released Physician Fee Schedule Proposed Rule from the Centers for Medicare and Medicaid Services ((CMS)) for 2022.According to analys...
Allied Healthcare Products (AHPI) -24%.Glaukos (GKOS) -21% comments on the centers for medicare and medicaid services 2022 proposed physician fee scheduleAllena Pharmaceuticals (ALNA) -20% after launches $28M direct offeringIMARA (IMRA) -15% after secures $50M capital...
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today commented on the recently released Centers for Medicare and Medicaid Services (CMS) Calen...
News, Short Squeeze, Breakout and More Instantly...
Conference Call and Webcast Scheduled for 1:30 p.m. PT Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release second quarter 2024 fin...
Shares of Glaukos Corporation (NYSE: GKOS) traded at a new 52-week high today and are currently trading at $120.11. So far today, approximately 152.81k shares have been exchanged, as compared to an average 30-day volume of 541.53k shares. Glaukos Corporation, an ophthalmic medical technology ...
2024-07-01 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...